If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBanco Santander Regulatory News (BNC)

Share Price Information for Banco Santander (BNC)

Share Price is delayed by 15 minutes
Get Live Data
1,056.00    22.00 (2.13%)
Bid:
1,060.00
Ask:
1,064.00
Spread: 4.00 (0.377%)
Market Cap: £151.30b
BNC Live PriceLast checked at - London Stock Exchange

Intraday Banco Santander Share Chart

Capital increase timeline

27 Oct 2020 17:59

RNS Number : 3972D
Banco Santander S.A.
27 October 2020
 

 

 

Banco Santander, S.A. ("Banco Santander" or the "Bank" or "Santander"), pursuant to the provisions of the Spanish Securities Market Act (Ley del Mercado de Valores), hereby announces the following:

 

OTHER RELEVANT INFORMATION

 

At the general meeting held today, shareholders passed a resolution to increase share capital against reserves (hereinafter, the 'Capital Increase'). If approved by the Bank's Executive Committee, the Capital Increase will be used to pay out approximately 0.10 euros per share in the form of newly issued shares as announced on 29 July 2020. The timeline for the Capital Increase is as follows:

· 12 November 2020. Execution of the Capital Increase and announcement of the number of rights required to receive one share.

· 13 November 2020 (23:59 hours CET). Reference date to participate in the Capital Increase (last trading date). Those who acquired their shares in the Bank by this date (inclusive) and appear as shareholders in the registries of Iberclear at 23:59 CET on 17 November 2020, will be entitled to take part in the Capital Increase.

· 16 November 2020. Start of the rights trading period. Santander shares will trade ex-coupon (ex-date).

· 30 November 2020. End of the rights trading period.

· 4-10 December 2020. Procedures for registering the Capital Increase and admitting new shares to trading on Spanish securities markets.

· 11 December 2020. Start of ordinary trading of the new shares on Spanish securities markets, subject to required authorisation.[1] Shareholders receive their new shares.

 

Boadilla del Monte (Madrid), 27 October, 2020

 

 

[1] Estimated date. The Bank shall also request that the new shares be admitted to trading on any foreign securities markets where it is listed.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBRBDGRUDDGGR
Date   Source Headline
16th Oct 202511:12 amRNSBuyback programme: transactions 9-15Oct
9th Oct 202511:05 amRNSBuyback programme: transactions 2-8Oct
3rd Oct 20252:58 pmRNSMoody's has upgraded Santanders rating
2nd Oct 20255:15 pmRNSDirector/PDMR Shareholding
2nd Oct 202511:07 amRNSBuyback programme: Transactions 25Sept-1Oct
30th Sep 20252:23 pmRNSDividend approval
30th Sep 202511:56 amRNSTotal Voting Rights
25th Sep 202511:12 amRNSBuyback programme: transactions 18-24Sept
18th Sep 202511:04 amRNSBuyback programme: transactions 11-17Sept
11th Sep 20254:54 pmRNSDirector/PDMR Shareholding
11th Sep 202511:07 amRNSBuyback programme: transactions 4-10Sept
4th Sep 202511:04 amRNSBuyback programme: transactions 28Aug-3Sept
29th Aug 20254:35 pmRNSTotal Voting Rights
29th Aug 202511:34 amRNSModification of internationalization covered bonds
28th Aug 202511:04 amRNSBuyback programme: transactions 21-27Aug
21st Aug 202511:04 amRNSBuyback programme: transactions 14-20Aug
14th Aug 202511:08 amRNSBuyback programme: transactions 7-13Aug
11th Aug 202511:09 amRNSDirector/PDMR Shareholding
7th Aug 202511:09 amRNSBuyback programme: transactions 31Jul - 6Aug
1st Aug 20255:48 pmRNSStress test Results
31st Jul 20254:57 pmRNSTotal Voting Rights
31st Jul 202512:07 pmRNSHalf-year Report
30th Jul 20257:00 amRNS1st Half 25 results report & earnings presentation
30th Jul 20257:00 amRNSFirst Half 2025 Results - Press release
30th Jul 20257:00 amRNSCommencement of a program to repurchase own shares
23rd Jul 202511:11 amRNSNotice of First Half 2025 Results
2nd Jul 20257:00 amRNSPresentation to analysts about transaction on TSB
1st Jul 20256:20 pmRNSSantander to acquire TSB. Analysts meeting notice
1st Jul 20252:55 pmRNSInvitation to buy outstanding preferred securities
30th Jun 202511:55 amRNSTotal Voting Rights
27th Jun 20254:49 pmRNSDirector/PDMR Shareholding
27th Jun 20254:47 pmRNSDirector/PDMR Shareholding
25th Jun 20257:00 amRNSInvitation to buy outstanding preferred securities
24th Jun 20257:48 amRNSInvitation to buy outstanding preferred securities
20th Jun 20255:16 pmRNSDirector/PDMR Shareholding
10th Jun 20253:54 pmRNSFurther re Capital reduction
10th Jun 20253:36 pmRNSDirector/PDMR Shareholding
3rd Jun 20252:38 pmRNSTotal Voting Rights
3rd Jun 202510:00 amRNSCapital reduction following completion of program
2nd Jun 202512:08 pmRNSTotal Voting Rights
29th May 202511:12 amRNSBuyback programme: transactions 22-28May
22nd May 202511:05 amRNSBuyback programme: transactions 14-21May
21st May 202512:41 pmRNSDirector/PDMR Shareholding
20th May 202512:57 pmRNSDirector/PDMR Shareholding
14th May 20255:36 pmRNSDirector/PDMR Shareholding
14th May 20253:33 pmRNSBuyback programme: transactions 7-13May
13th May 20254:11 pmRNSDirector/PDMR Shareholding
9th May 20251:17 pmRNSDirector/PDMR Shareholding
9th May 20251:10 pmRNSDirector/PDMR Shareholding
7th May 20255:26 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.